Company research
ALBIREO PHARMA, INC.
CIK 1322505Updated Nov 16, 2026
Securities
Historical securities (1)
ALBO · NASDAQ · equity · closed Mar 2, 2023Name history
Biodel Inc · through Nov 2, 2016
ALBO price & chart
Historical security
This listing closed Mar 2, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 302,051,000Source | 285,607,000Source | 165,069,000Source | 185,466,000Source |
| Property, Plant and Equipment, NetUSD | 668,000Source | 478,000Source | 597,000Source | 187,000Source |
| GoodwillUSD | 17,260,000Source | 17,260,000Source | 17,260,000Source | 17,260,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 248,107,000Source | 251,272,000Source | 131,843,000Source | 163,885,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 3,272,000Source | — | — | — |
| Inventory, NetUSD | 194,000Source | — | — | — |
| Assets, CurrentUSD | 268,930,000Source | 261,865,000Source | 141,799,000Source | 167,650,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | — | 10,593,000Source | 9,956,000Source | 850,000Source |
| Operating Lease, Right-of-Use AssetUSD | 12,000,000Source | 4,100,000Source | 4,700,000Source | — |
| Other Assets, NoncurrentUSD | 15,193,000Source | 6,004,000Source | 5,413,000Source | 369,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 126,443,000Source | 104,376,000Source | 71,908,000Source | 62,829,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 193,000Source | 191,000Source | 127,000Source | 120,000Source |
| Additional Paid in CapitalUSD | 475,390,000Source | 456,472,000Source | 245,769,000Source | 214,694,000Source |
| Retained Earnings (Accumulated Deficit)USD | -300,850,000Source | -266,820,000Source | -159,187,000Source | -96,470,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 1,105,000Source | -8,612,000Source | 6,452,000Source | 4,293,000Source |
| Stockholders' Equity Attributable to ParentUSD | 175,608,000Source | 181,231,000Source | 93,161,000Source | 122,637,000Source |
| Liabilities and EquityUSD | 302,051,000Source | 285,607,000Source | 165,069,000Source | 185,466,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 45,347,000Source | 25,282,000Source | 18,924,000Source | 12,825,000Source |
| Operating Lease, Liability, CurrentUSD | 1,396,000Source | 640,000Source | 561,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | 10,818,000Source | 3,563,000Source | 4,186,000Source | — |
| Other Liabilities, NoncurrentUSD | 10,960,000Source | 3,579,000Source | 4,270,000Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 35,951,000Source | 19,051,000Source | 13,486,000Source | 8,165,000Source |
cash flow · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -34,030,000Source | -107,633,000Source | -62,717,000Source | -46,111,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 274,000Source | 192,000Source | 127,000Source | 45,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 15,931,000Source | 14,615,000Source | 7,578,000Source | 5,546,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 3,291,000Source | — | — | 597,000Source |
| Increase (Decrease) in InventoriesUSD | 194,000Source | — | — | — |
| Increase (Decrease) in Accounts PayableUSD | 1,336,000Source | 275,000Source | 577,000Source | — |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -107,559,000Source | -101,029,000Source | -52,919,000Source | -26,802,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 102,922,000Source | -78,000Source | -540,000Source | -47,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 465,000Source | 78,000Source | 540,000Source | 61,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 230,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 2,759,000Source | 220,276,000Source | 23,504,000Source | 139,182,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -3,165,000Source | 119,429,000Source | -32,042,000Source | 110,654,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 248,107,000Source | 251,272,000Source | 131,843,000Source | 163,885,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | — | — | 20,000Source | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -1,287,000Source | 260,000Source | -2,087,000Source | -1,679,000Source |
| Additional Financial Items | ||||
| Accretion ExpenseUSD | 12,528,000Source | 10,778,000Source | 8,360,000Source | 6,975,000Source |
| Share-based Payment Arrangement, ExpenseUSD | 15,931,000Source | 14,615,000Source | 7,578,000Source | 5,546,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 383,000Source | 248,000Source | — | — |
| DepreciationUSD | 300,000Source | 200,000Source | 100,000Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -10,423,000Source | 14,573,000Source | -4,006,000Source | — |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | — | — | -4,631,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | 14,000Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | 103,387,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | 42,448,000Source | 22,963,000Source | 18,061,000Source |
| GoodwillUSD | 17,260,000Source | 17,260,000Source | 17,260,000Source | 17,260,000Source |
| Goodwill, Impairment LossUSD | 0Source | — | 0Source | — |
| Income Tax Expense (Benefit)USD | — | — | — | 20,000Source |
| Inventory Write-downUSD | 0Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -34,030,000Source | -107,633,000Source | -62,717,000Source | -46,111,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -34,030,000Source | -107,633,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 3,691,000Source | -3,363,000Source |
| Operating ExpensesUSD | 162,708,000Source | 104,579,000Source | 70,748,000Source | 50,630,000Source |
| Other Operating Income (Expense), NetUSD | -10,617,000Source | 14,646,000Source | -2,210,000Source | -837,000Source |
| Proceeds from Issuance of Common StockUSD | 241,000Source | 193,265,000Source | 20,775,000Source | 94,150,000Source |
| Proceeds from Stock Options ExercisedUSD | 2,748,000Source | — | 2,729,000Source | 507,000Source |
income statement · annual statements
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Total RevenueUSD | 40,579,000Source | 8,308,000Source | 9,636,000Source | 12,740,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 69,569,000Source | — | — | — |
| Operating Income (Loss)USD | -123,485,000Source | -96,271,000Source | -61,112,000Source | -37,890,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -34,030,000Source | -107,633,000Source | -62,717,000Source | -46,091,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | 20,000Source |
| Net Income (Loss) Attributable to ParentUSD | -34,030,000Source | -107,633,000Source | -62,717,000Source | -46,111,000Source |
| Earnings Per Share, BasicUSD per share | -1.77Source | — | — | — |
| Earnings Per Share, DilutedUSD per share | -1.77Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 19,220,846Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 19,220,846Source | — | — | — |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 0Source | 0Source | — | 20,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -10,423,000Source | 14,573,000Source | -4,006,000Source | — |
| General and Administrative ExpenseUSD | — | 42,448,000Source | 22,963,000Source | 18,061,000Source |
| Goodwill, Impairment LossUSD | 0Source | — | 0Source | — |
| Gross ProfitUSD | 39,223,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -18,603,000Source | -86,041,000Source | -29,337,000Source | -13,951,000Source |
| Interest Income (Expense), NetUSD | — | — | -5,296,000Source | -4,838,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -13,932,000Source | -11,362,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -34,030,000Source | -107,633,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 3,691,000Source | -3,363,000Source |
| Operating ExpensesUSD | 162,708,000Source | 104,579,000Source | 70,748,000Source | 50,630,000Source |
| Other Operating Income (Expense), NetUSD | -10,617,000Source | 14,646,000Source | -2,210,000Source | -837,000Source |
| Research and Development ExpenseUSD | 82,522,000Source | 76,777,000Source | 45,575,000Source | 31,732,000Source |